Subject: Discover the new EASL Takeaway on Viral Hepatitis
From: EASL Office <[email-masked]>
To: [email-masked]
Date: Thu, 24 Sep 2020 13:24:01 +0000

24 September 2020

Read online

Digital ILC 2020 Takeaways – Viral Hepatitis Expert Discussions

As part of EASL’s ground-breaking Digital ILC 2020, the EASL Takeaways look back on key topics from the congress, with leading experts discussing the most impactful science and putting it into perspective.

This episode sees 3 internationally renowned experts in viral hepatitis – Professor Ulrich Spengler, Professor Geoffrey Dusheiko and Dr. Tobias Böttler – recap the key developments revealed at the congress. The panel discussed different studies ranging from the Stop-NUC trial  and the potential for durable immune control and functional cure in HbeAg-negatuive patients, as well as new data on novel therapies and new experimental observations.

The EASL Takeaways are hosted on EASL Campus. To access them, please log in with your credentials. If you do not have an EASL Campus account yet, please create one here, free of charge.

Watch the Viral Hepatitis EASL Takeaways now

Missed the previous EASL Takeaways?

Watch them now

Save the date for the next EASL Takeaways

Find out more

Discover the open access Viral Hepatitis content on EASL Campus

On EASL Campus you can find diverse open access educational resources on Viral Hepatitis. Here is a selection:

new online course on the "Management of Hepatitis B infection"

bimonthly EASL Quizzes

Best of ILC Slide Decks

didactic slide decks on EASL’s Clinical Practice Guidelines and recommendations

over 150 webcasts

over 100 resources from our dedicated conferences

Create a free account or use your existing one and start learning from worldwide experts.

Access EASL Campus now

Digital International Liver Congress™ 2020 is now on-demand

Viral Hepatitis at Digital ILC 2020

Viral Hepatitis was a major topic at Digital ILC 2020. Access the on-demand content to discover the latest research comprising over 60 resources (videos, posters, abstract & interactive sessions, expert panel discussions abstracts, etc.).

Best of Digital ILC 2020 Slide Deck on Viral Hepatitis is available exclusively to Digital ILC 2020 registered delegates.

Download your copy now.

View the entire Digital ILC 2020 congress content now available on-demand for registered delegates.

If you registered, you can use your credentials to access the resources.

If you have not yet registered for Digital ILC 2020, please create an account below.

Register today for full access to Digital ILC 2020 on-demand

EASL Recommendations on Treatment of Hepatitis C

We are glad to inform you that the final update of the EASL Recommendations on Treatment of Hepatitis C is now available on the EASL website.

Global survey of hepatitis providers/program managers: COVID-19 impact on hepatitis prevention, testing, and treatment

In collaboration with Project ECHO networks, EASL, AASLD, CASL and CHAI, the Coalition for Global Hepatitis Elimination (CGHE) is distributing a global survey to better understand the impact of COVID-19 on hepatitis services and what mitigation strategies have been successfully deployed.

Click and take the survey in English, French, and Spanish.

Scaling-up hepatitis testing to achieve the SDGs: challenges and opportunities from the COVID-19 response

Wednesday, 28th September at 10:00 AM CET

Join the UN General Assembly Side Event organized by the CGHE where together leading diagnostic organizations, country representatives, and public health institutions will discuss the challenges and opportunities in hepatitis testing presented by COVID-19.

Register here.

Addressing HIV and viral hepatitis during the COVID-19 pandemic

23 and 24 September 2020 10:00 AM CET

The WHO Regional Office for Europe jointly with European Center for Disease Prevention and Control (ECDC) is organizing a virtual meeting with major stakeholders of communicable diseases to exchange information and good practices on the maintenance of essential TB, HIV and viral hepatitis services during the COVID-19 pandemic and beyond.

Prof. Maria Buti, EASL Policy and Public Health Chairperson will present the latest EASL policy statement on HCV elimination and harm reduction.

Register here!

For the latest news on education and hepatology,

follow us on Twitter @EASLedu and @EASLnews

Forward to a friend or colleague

EASL’s mission is supported by an unrestricted education grant from

Abbvie and Bristol-Myers Squibb.

EASL, The Home of Hepatology

7 rue Daubin, 1203 Geneva, Switzerland

+41 22 807 03 60

www.easl.eu

[email-masked]

Update your preferences or unsubscribe